Adicet Bio Inc [NASDAQ: ACET] closed the trading session at $0.53.
The stocks have a year to date performance of -45.34 percent and weekly performance of 17.60 percent. The stock has been moved at -62.44 percent over the last six months. The stock has performed -32.37 percent around the most recent 30 days and changed -42.82 percent over the most recent 3-months.
If compared to the average trading volume of 824.12K shares, ACET reached to a volume of 350324 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Adicet Bio Inc [ACET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACET shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACET stock is a recommendation set at 1.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Adicet Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 30, 2024. The new note on the price target was released on September 11, 2024, representing the official price target for Adicet Bio Inc stock.
The Average True Range (ATR) for Adicet Bio Inc is set at 0.07 The Price to Book ratio for the last quarter was 0.23, with the Price to Cash per share for the same quarter was set at 2.13.
ACET stock trade performance evaluation
Adicet Bio Inc [ACET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.60. With this latest performance, ACET shares dropped by -32.37% in over the last four-week period, additionally sinking by -62.44% over the last 6 months – not to mention a drop of -75.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACET stock in for the last two-week period is set at 34.39, with the RSI for the last a single of trading hit 33.93, and the three-weeks RSI is set at 35.57 for Adicet Bio Inc [ACET]. The present Moving Average for the last 50 days of trading for this stock 0.7977, while it was recorded at 0.5583 for the last single week of trading, and 1.1262 for the last 200 days.
Adicet Bio Inc [ACET]: An insightful look at the core fundamentals
Adicet Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.29 and a Current Ratio set at 9.29.
Earnings per share (EPS) analysis for Adicet Bio Inc [ACET] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adicet Bio Inc go to 5.15%.
Adicet Bio Inc [ACET]: Institutional Ownership
There are presently around $69.24%, or 71.18%% of ACET stock, in the hands of institutional investors. The top three institutional holders of ACET stocks are: ORBIMED ADVISORS LLC with ownership of 11.45 million shares, which is approximately 12.6303%. TANG CAPITAL MANAGEMENT LLC, holding 8.22 million shares of the stock with an approximate value of $$9.94 million in ACET stocks shares; and TANG CAPITAL MANAGEMENT LLC, currently with $$9.12 million in ACET stock with ownership which is approximately 8.3205%.
